VEGFA is well documented as a key cancer driver that is secreted by both cancer cells and cancer stromal cells in the TME and that not only promotes tumor angiogenesis (14, 15) but also suppresses tumor immune responses (16, 17). This evidence concerns the gene VEGFA and neoplasm.